report banner

News in English

PostNews: Press Release

PHI Focuses on Biomanufacturing — Appoints New CEO and Chairman

The Board of Directors of PHI has appointed the company’s CFO, Patrik Eschricht, as the new CEO. In addition, the former CEO and founder of PHI, Peter Egelberg, has been appointed executive chairman of the Board.
Learn more …
PostNews: Interim Report
Serious concentrated female microbiologist in sterile clothing and safety goggles sitting at table and dropping reagent in petri dish while doing research in laboratory

Interim Report 2 2022/23

The online sales and lead generation strategy continues to deliver. As a result, sales from August to October this year reached 2.7 KSEK — an increase of 50 % compared to any previous corresponding period.
Learn more …
PostNews
PHI CSO Kersti Alm at Biostock

BioStock: PHI on the alliance for cell-based biomanufacturing

Kersti Alm, CSO at PHI, visited BioStock’s studio to talk about the recently created alliance for advancing cell-based biomanufacturing and PHI’s pivotal role in the collaboration.
Learn more …
PostNews: Press Release

PHI Is Opening A New Development Office In The US

As a result of the newly created alliance for advancing cell-based biomanufacturing which was recently communicated, PHI is taking the next step in its investment into regenerative medicine by opening an office in the Innovation Quarter in Winston-Salem.
Learn more …
PostNews
PHI part of new regenerative medicine alliance

BioStock: PHI part of new regenerative medicine alliance

BioStock contacted Product Manager Lisa Lindström to learn more about PHI’s newly formed technology development alliance for regenerative medicine and what excites her about the future.
Learn more …
PostNews: Press Release
Cell culture quality control at a leading contract manufacturer of cell therapies.

PHI, SAS, QIAGEN and BioSpherix form Alliance to Advance Cell-based Biomanufacturing

In association with the Wake Forest Institute for Regenerative Medicine, PHI, BioSpherix, analytics leader SAS and QIAGEN have created a technology development alliance to create the AI-based process control tools needed for automated biomanufacturing.
Learn more …
167891030